BioHealth News Archive
NewLink in $1 billion deal with Roche to develop cancer drug – Reuters
NewLink Genetics Corp (NLNK.O) said it entered into an agreement with Roche Holding AG (ROG.VX) to develop NewLink's cancer immunotherapy, making the Ebola vaccine…
Read More
Emergent BioSolutions among three under consideration for Ebola drug manufacturing – Baltimore Business Journal
Biopharmaceutical company Emergent BioSolutions could begin manufacturing an experimental Ebola drug at its Baltimore facility. Rockville-based Emergent is one of three advanced laboratories asked…
Read More
ATCC Adds New Customer-driven Format to its Quality Control Standards Portfolio
ATCC, the premier global biological materials resource and standards organization, announces the release of ATCC® Minis to support quality control (QC) testing in pharmaceutical…
Read More
Blazing hot Limerick biotech company sold for $150m – Limerick Leader
A BIOTECHNOLOGY company founded by Limerick man Kieran Curran has been snapped up for $150m by a US firm. GenCell Biosystems, a company based…
Read More
University of Maryland researchers begin human trials of Ebola vaccine – The Diamondback
One of the two Ebola-infected Dallas nurses was admitted to a National Institutes of Health biocontainment unit in Bethesda on Thursday, just as researchers…
Read MoreMaryland firms hauled in $89M in venture capital in Q3 – Technical.ly Baltimore
Venture capital investments in Maryland are still working their way back up, according to a report released this week by PricewaterhouseCoopers and the National Venture Capital…
Read More
Interactive Map: Where The Venture Capital Dollars Are Going – Venture Capital Dispatch – WSJ
In the Boston-versus-New York rivalry, the Red Sox and the Yankees were also-rans this baseball season. Now, Massachusetts and New York are in another…
Read More
Applications open for DreamIt Health’s second cohort – Technical.ly Baltimore
Applications are now open for DreamIt Health’s second Baltimore cohort. DreamIt Ventures will accept applications through Dec. 5, according to a DreamIt blog post. The first…
Read More
GSK creates $5 million Innovation Challenge Fund
A $5 million Innovation Challenge Fund (ICF), to encourage and support academic groups and small companies in collaborative efforts in the development of bioelectronic…
Read More
Shock W.H.O. report: Ebola has 42-day incubation period, not 21 days! – NaturalNews.com
A jaw-dropping report released by the World Health Organization on October 14, 2014 reveals that 1 in 20 Ebola infections has an incubation period…
Read More
AstraZeneca and MedImmune announce new collaboration with Cambridge University – Cambridge News
ASTRAZENECA has announced a four-way collaboration which will strengthen the pharmaceutical giant's link with Cambridge University. The firm, together with its biologics research and…
Read More
Developing a global digital strategy – McKinsey & Company
I joined J&J Consumer Companies about four years ago to start its Digital Center of Excellence. Our role initially was to build capabilities and…
Read More
Pharma giants invest €23m in Bicycle – European Biotechnology News
Bicycle’s founding venture capitalist (VC), Atlas Ventures joined forces this month with SV Life Sciences and three corporate VCs – Novartis (NVS) Venture Fund,…
Read More
Illumina Admits First Startup Accelerator Class – Xconomy
Bioinformatics giant Illumina (NASDAQ: ILMN) is getting into the accelerator game, along with other players in the life sciences and other fields. On Wednesday…
Read More
CIT releases annual report on research commercialization in Virginia – Augusta Free Press
The Center for Innovative Technology (CIT) announced this week the release of the Commonwealth Research Commercialization Fund (CRCF) annual report for FY2014, showing growth in…
Read More